About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
2019 ASTRO Annual Meeting
IASLC 2019 World Conference on Lung Cancer
2019 Quality Care Symposium
2019 Debates and Didactics in Hematology and Oncology
2019 NCCN Policy Summit
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
2013 Global Women’s Cancer Summit
Today In Oncology
Cost of Treatment, Prior Authorization of Treatment Plans May Cause Barriers to Care
FDA Grants Approval to Lenvatinib/Pembrolizumab in Advanced Endometrial Cancer, Announces Project Orbis
Olaparib Improves Outcomes in Ovarian Cancer
Does PTSD Increase the Risk of Developing Ovarian Cancer?
Does the Addition of Bevacizumab to Erlotinib in Advanced EGFR-Mutant NSCLC Improve PFS?
Most Read Stories
Olaparib Monotherapy Improves Outcomes in
-Mutated, Platinum-Sensitive Relapsed Ovarian Cancer
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
WCLC 2019: First-Line Nivolumab/Ipilimumab in Special Populations With NSCLC
'Oral Cryotherapy' for Patients Undergoing Oxaliplatin-Based Chemotherapy
Management of HER2-Positive Breast Cancer: Business as Usual?
Most Viewed Videos
Ryan Huey, MD, on the Financial Toxicity of Early-Phase Clinical Trials
Linda D. Bosserman, MD, on Pathways for Personalized Precision Medicine and Value
Matthew B. Schabath, PhD, on Addressing Cultural Barriers to Equality in Oncology Among Sexual and Gender Minorities
Angela M. Stover, PhD, on Patient-Reported Outcome Performance Measures for Oncology Practice
Nadine Housri, MD, on Online Tumor Boards: A New Resource for Practicing Oncologists
© 2019 HSP News Service, L.L.C.